Beijing Hotgen Biotech Co., Ltd. (SHA:688068)
China flag China · Delayed Price · Currency is CNY
100.71
-5.27 (-4.97%)
May 14, 2025, 2:45 PM CST

Beijing Hotgen Biotech Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020 2016 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
Operating Revenue
488.01510.89537.93,5325,307511.67
Upgrade
Other Revenue
--3.3524.4162.651.86
Upgrade
Revenue
488.01510.89541.253,5575,369513.53
Upgrade
Revenue Growth (YoY)
7.39%-5.61%-84.78%-33.76%945.54%144.06%
Upgrade
Cost of Revenue
1.6-209.841,7662,254189.95
Upgrade
Gross Profit
486.41510.89331.411,7903,116323.59
Upgrade
Selling, General & Admin
6.97-262.89483.58404.26161.44
Upgrade
Research & Development
-2.24-131.45191.14131.9247.61
Upgrade
Other Operating Expenses
681.86682.833.569.25.040.88
Upgrade
Operating Expenses
686.59682.83384.74695.26541.92211.13
Upgrade
Operating Income
-200.18-171.94-53.331,0952,574112.46
Upgrade
Interest Expense
-0.42--1.01-2.32-1.27-0.45
Upgrade
Interest & Investment Income
33.7-39.5934.5234.268.42
Upgrade
Currency Exchange Gain (Loss)
--4.314.95-14.641.7
Upgrade
Other Non Operating Income (Expenses)
-3.81-4.07-1.173.31-4.82-0
Upgrade
EBT Excluding Unusual Items
-170.71-176.01-11.611,1352,587122.12
Upgrade
Gain (Loss) on Sale of Investments
-32.74--22.317.523.12-
Upgrade
Gain (Loss) on Sale of Assets
-1.75--0.64-0.34-14.21-0.18
Upgrade
Asset Writedown
-0.03--36.95-70.06-8.51-0.14
Upgrade
Other Unusual Items
--85.022.6314.225.62
Upgrade
Pretax Income
-205.22-176.0113.51,0752,582127.42
Upgrade
Income Tax Expense
2.13.22-1.55150.1379.4416.13
Upgrade
Earnings From Continuing Operations
-207.33-179.2315.05925.122,202111.3
Upgrade
Minority Interest in Earnings
-0.97-12.3319.62-16.610.77
Upgrade
Net Income
-208.29-179.2327.38944.742,186112.07
Upgrade
Net Income to Common
-208.29-179.2327.38944.742,186112.07
Upgrade
Net Income Growth
---97.10%-56.78%1850.41%230.80%
Upgrade
Shares Outstanding (Basic)
949288919292
Upgrade
Shares Outstanding (Diluted)
949288929292
Upgrade
Shares Change (YoY)
8.41%4.59%-3.88%-0.14%-0.12%23.13%
Upgrade
EPS (Basic)
-2.21-1.940.3110.3323.751.22
Upgrade
EPS (Diluted)
-2.21-1.940.3110.2823.751.22
Upgrade
EPS Growth
---96.98%-56.72%1852.80%168.66%
Upgrade
Free Cash Flow
---465.31413.542,246-7.65
Upgrade
Free Cash Flow Per Share
---5.274.5024.40-0.08
Upgrade
Dividend Per Share
--0.200-3.3781.014
Upgrade
Dividend Growth
----233.34%400.00%
Upgrade
Gross Margin
99.67%100.00%61.23%50.34%58.03%63.01%
Upgrade
Operating Margin
-41.02%-33.66%-9.85%30.79%47.93%21.90%
Upgrade
Profit Margin
-42.68%-35.08%5.06%26.56%40.71%21.82%
Upgrade
Free Cash Flow Margin
---85.97%11.63%41.82%-1.49%
Upgrade
EBITDA
--111.876.741,1842,631141.61
Upgrade
EBITDA Margin
--21.90%1.24%33.30%49.00%27.57%
Upgrade
D&A For EBITDA
-60.0760.0789.3957.529.15
Upgrade
EBIT
-200.18-171.94-53.331,0952,574112.46
Upgrade
EBIT Margin
-41.02%-33.66%-9.85%30.79%47.93%21.90%
Upgrade
Effective Tax Rate
---13.96%14.70%12.66%
Upgrade
Revenue as Reported
--541.253,5575,369513.53
Upgrade
Advertising Expenses
--13.0855.0868.417.17
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.